Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target group comprises a heterogeneous collection of highly reactive chemical entities and metal ions that collectively drive oxidative and carbonyl stress within biological systems. Reactive oxygen species (ROS), such as superoxide and hydrogen peroxide, and reactive carbonyl species (RCS), such as malondialdehyde and methylglyoxal, are natural byproducts of aerobic metabolism and lipid peroxidation that can damage cellular macromolecules including DNA, proteins, and lipids (Halliwell & Gutteridge, 2015, Free Radicals in Biology and Medicine). Divalent metal ions like Fe2+ and Cu2+ play a critical role in this process by catalyzing the Fenton reaction, which converts relatively stable peroxides into highly toxic hydroxyl radicals (Kehrer, 2000, Toxicology). Pathological accumulation of these species is a hallmark of chronic diseases, including Alzheimer's disease, atherosclerosis, and diabetic complications, where they promote inflammation and programmed cell death (Baynes & Thorpe, 2000, Diabetes). Therapeutic intervention typically involves the use of antioxidants to scavenge radicals, carbonyl traps to neutralize electrophilic species, or chelating agents to sequester metal ions and prevent radical initiation (Sies & Jones, 2020, Nature Reviews Molecular Cell Biology). However, because low levels of ROS are essential for physiological signaling and host defense, non-specific targeting remains a significant clinical challenge.
Free radical scavenging, chemical neutralization of electrophilic carbonyls, and chelation of redox-active divalent metal ions to prevent Fenton-type reactions.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific reactive oxygen species, reactive carbonyls, and divalent metal ions (ROS/RCS/Metal ions).